Henry Schein (HSIC) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts HSIC Hot Sheet
Price: $90.12 -0.68%
Financial Fact:
Restructuring costs: 5.37M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Restructuring costs: 5.37M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Henry Schein (NASDAQ: HSIC) reported Q3 EPS of $1.52, $0.05 better than the analyst estimate of $1.47. Revenue for the quarter came in at $2.7 billion versus the consensus estimate of $2.7 billion.
Henry Schein sees FY2015 EPS of $5.90-$5.96, versus prior guidance of $5.90-$6.00 and the consensus of $5.93.
For earnings history and earnings-related data on Henry Schein (HSIC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
